Atrioventricular (AV) Valves Summit 2023
Published: 03 November 2023
-
Views:
3854
-
Likes:
7
-
Views:
3854
-
Likes:
7
-
10m 34sPart 1 | Session 1 Summit Overview and Optimising MR and TR Treatments Francesco Maisano, Marta Sitges
-
10m 41sPart 1 | Session 2 Summit Overview: Trending Topics in AV Valves Ralph Stephan von Bardeleben
-
14m 15sPart 2 Mitral and Tricuspid Learnings Lluis Asmarats, Tomás Benito González
-
15m 57sPart 3 Exploring Controversies: Staged, Concomitant and Repair, Replacement Niklas Schofer, Tobias Friedrich Ruf
-
5m 39sPart 4 | Session 1 TEER in the UK: Insights into its Origins, Progress and Future Prospects Michael Mullen
-
8mPart 4 | Session 2 TEER vs TAVI: Bridging the Gap in Potential Undertreatment Corrado Tamburino
-
8m 18sPart 5 Exploration de l'Évolution de la Thérapie de Régurgitation Mitrale Secondaire (RMS) en France Guillaume Leurent
Overview
In this series of short interviews and discussions filmed at AV Valves Summit 2023, the faculty delve into sharing invaluable insights and expert opinion on transcatheter mitral and tricuspid intervention.
They examine a range of topics which include the development of TEER, the importance of quality of life, repair vs replacement and how to best shape the future of MR and TR treatment.
The AV Valves Summit led by course directors Prof Francesco Maisano (San Raffaele Hospital, Milan, IT), Prof Marta Sitges (University of Barcelona, Barcelona, ES), Prof Marco Metra (University of Brescia, Brescia, IT) and Prof Ralph Stephan von Bardeleben (University Medical Center of Mainz, Mainz, DE) provided a platform to advance knowledge and shape the trajectory of this treatment in cardiovascular healthcare.
Learning Objectives
- Gain an understanding of the anatomy of mitral and tricuspid valves to inform appropriate intervention strategies
- The importance of incorporating quality of life considerations into patient management plans, aiming to improve the overall well-being of individuals undergoing valve interventions
- Learn to identify, prevent, and manage complications associated with mitral and tricuspid valve interventions to ensure patient safety
- Explore evidence-based strategies for decision-making in heart failure management
- Assess emerging trends and future innovations impacting the trajectory of mitral and tricuspid valve therapies
Target audience
- Interventional Cardiologist
- Echocardiographer
- Heart Failure Specialist
- Cardiac Surgeon
More from this programme
Part 1
Course Directors
Part 2
Mitral and Tricuspid Learnings
1 session | |
Mitral and Tricuspid Learnings | Watch now |
Part 3
Exploring Controversies
Part 4
Exploring Transcatheter Edge to Edge Repair
Part 5
RMS en France
Part 6
AV Valves Summit at a Glance
1 session | |
AV Valves Summit at a Glance | Watch now |
Faculty Biographies
![Guillaume Leurent](https://assets.radcliffecardiology.com/s3fs-public/author/2023-09/Guillaume-Leurent.jpg?VersionId=0CEsH7Y2IeTXuQOBNngrfGmUIXRBc4nW)
Guillaume Leurent
Interventional cardiologist
Dr Guillaume Leurent is an interventional cardiologist at the University Hospital of Rennes, Rennes, FR. His scientific focus encompasses diverse cardiovascular pathologies, including myocardial infarction, sudden arrest, takotsubo syndrome, and postpartum cardiomyopathies. Dr Leurent's expertise spans coronary arteriography, angioplasty, cardiac MRI, and intensive care. He has published numerous original articles on these topics, contributing significantly to the field of cardiology. His holistic approach to patient care, coupled with his research contributions, establishes him as a respected figure in cardiovascular medicine, with a lasting impact on patient outcomes and medical advancements.
![Marta Sitges](https://assets.radcliffecardiology.com/s3fs-public/author/2024-03/Marta%20Sitges.png?VersionId=cq6o8CYxSa7_lT1n9VW5R5p_OcatbX9i)
Marta Sitges
Director, Cardiovascular Institute
Prof Marta Sitges is a senior consultant non-invasive cardiologist at the Cardiovascular Institute in Hospital Clinic and Professor of Medicine at the University of Barcelona. She has also been the Director of the Cardiovascular Institute since October 2015.
Her main clinical practice is related to clinical and interventional echocardiography, sports cardiology and heart valve disease. She has an extensive publication track in these fields with participation in leading National and International meetings, she has received more than 60 peer reviewed grants and directed multiple MD and PhD thesis.
![Francesco Maisano](https://assets.radcliffecardiology.com/s3fs-public/author/2022-06/Francesco_Maisano.png?VersionId=ZJYeCwlg3b9pSIV7eeD_JsEEi6QHZG70)
Francesco Maisano
Head of Cardiac Surgery, Director of the Valve Center
Prof Maisano is Professor of Cardiac Surgery and Director of the Valve Center at San Raffaele Research Hospital in Milan.
Prof Maisano is a cardiac surgeon with large experience in standard cardiovascular treatments and innovative technologies, as well as cross-trained in interventional cardiology, with specific focus on structural interventions.
In his research, Prof Maisano was the principal investigator of the ACCESS EU Registry, the largest European registry monitoring the real-world results of MitraClip therapy. He is the co-inventor of a surgical annular prosthesis, which is now a standard surgical technique in the treatment of functional mitral valve regurgitation.
Prof Maisano is an Editorial Board member of Cardiac Failure Review.
![Francesco Bedogni](https://assets.radcliffecardiology.com/s3fs-public/author/2023-09/francesco-bedogni-removebg-preview.png?VersionId=lR1t9Qq3QDUT3bJug3FDqTTElktGYC7j)
Francesco Bedogni
MD
Prof Francesco Bedogni is the Director of the Clinical Cardiology, Interventional Cardiology, and Coronary Intensive Care Units (UTIC) at the IRCCS Policlinico San Donato, Milan, IT. He has authored over 320 scientific articles and abstracts, which have achieved significant bibliometric recognition. His contributions have appeared in prestigious journals such as Circulation, Journal of the American College of Cardiology, European Heart Journal, American Journal of Cardiology, QJM, Cardiology, Catheterisation and Cardiovascular Interventions, and Coronary Artery Disease.
Prof Francesco Bedogni serves as the Principal Investigator for numerous approval studies of CE and FDA-marked new devices in interventional cardiology.
He has participated as a Speaker and Moderator in 250 conferences both in Italy and abroad.
![Lluis Asmarats](https://assets.radcliffecardiology.com/s3fs-public/author/2023-11/Untitled%20design%20%283%29.png?VersionId=.x8BGwyT_NjfB9SvUUJSjhzsrHzDFN.V)
Lluis Asmarats
Dr Lluis Asmarats is an interventional cardiologist at Hospital de la Santa Creu i Sant Pau (Barcelona, ES) specialised in coronary and structural heart disease interventions. He served a fellowship in interventional and structural heart disease at the Quebec Heart and Lung Institute (Laval University, Quebec, CA), where he obtained his PhD in clinical medicine and biomedical sciences. His research interests focus on transcatheter therapies for structural heart disease.
![Tomás Benito González](https://assets.radcliffecardiology.com/s3fs-public/author/2023-09/benito.jpg?VersionId=jXxiZ2kT8_WbrQb63F_fV_FcFEZpTFnb)
Tomás Benito González
Interventional Cardiologist
Dr Tomás Benito González is an interventional cardiologist at the University Hospital of León, ES. His research interests are centred around ground-breaking areas such as percutaneous Mitral Valve Repair, percutaneous left atrial appendage closure, and the implications of Mitral Valve repair with Mitraclip, making significant contributions to the ongoing evolution of cardiac care.
![Ralph von Bardeleben](https://assets.radcliffecardiology.com/s3fs-public/author/2020-12/ralph_von_bardeleben.jpg)
Ralph von Bardeleben
Head of the Centre of Structural Heart Disease Interventions and the Heart Valve Centre
Prof Ralph Stephan von Bardeleben is the Head of the Center of Structural Heart Disease Interventions and the Heart Valve Center in Mainz, Germany
Prof Bardeleben is Past-President of the German working group on Echocardiography of the German Society of Cardiology and a member of several medical societies. He serves on the Clinical Program commission and at your region program of the ESC and is a reviewer for several peer-reviewed journals. Newly elected co-editor-in-chief of Echocardiography Journal.
He participates as PI, steering committee member and core laboratory in several medical device trials, including a German Federal Institute for Drugs and Medical Devices (BfArM)-approved first- or early-in-human medical device implant trials.